Probiotics in Pediatrics. A Review and Practical Guide

Leontien Depoorter1, Yvan Vandenplas1

  • 1Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, 1090 Brussels, Belgium.

Nutrients
|July 2, 2021
PubMed

Insights

Probiotics show benefits for pediatric conditions like infectious gastroenteritis and diarrhea prevention. However, more research is needed to establish specific strains, doses, and regimens for widespread use.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Probiotics, live microorganisms conferring health benefits, are increasingly studied in pediatrics.
  • Selected probiotic strains demonstrate efficacy in managing and preventing specific pediatric conditions.
  • Evidence suggests probiotics are generally well-tolerated with a low risk of adverse events.

Purpose of the Study:

  • To review current evidence on the efficacy of specific probiotics in pediatric conditions.
  • To guide pediatricians in the therapeutic and prophylactic use of probiotic strains.
  • To identify gaps in current research for probiotic application in children.

Main Methods:

  • Systematic review of available scientific literature.
  • Analysis of evidence for specific probiotic strains and pediatric indications.
  • Evaluation of study quality, heterogeneity, and risk of bias.

Main Results:

  • Probiotics are most effective for infectious gastroenteritis and preventing antibiotic-associated, *Clostridioides* difficile-associated, and nosocomial diarrhea.
  • Evidence supports the use of certain probiotics for specific pediatric conditions.
  • Study heterogeneity and bias limit broad consensus on optimal probiotic strains, doses, and regimens.

Conclusions:

  • Current evidence supports targeted probiotic use in specific pediatric conditions, particularly for diarrhea.
  • Lack of standardized, high-quality studies hinders widespread, systematic probiotic administration.
  • Further well-designed, strain-specific, dose-response studies are crucial for advancing probiotic therapy in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
48
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
548
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
64
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
469